Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
11/2002
11/27/2002EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002CN1094932C Synthesis of 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole
11/27/2002CN1094931C Antithrombotic organic nitrates
11/21/2002WO2002092584A1 Thiadiazole derivatives, pesticides for agricultural and horticultural use and usage thereof
11/21/2002WO2002092581A1 Heterocyclyl phenyl benzyl ethers used as fungicides
11/21/2002WO2002092574A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/21/2002US20020173529 Fungicide active substance combinations
11/21/2002US20020173469 Protease inhibitors
11/21/2002DE10138576A1 New substituted benzoylcyclohexenone derivatives useful as antimicrobials and herbicides, especially for selective application in transgenic crops
11/21/2002DE10135549A1 New 4-heterocyclyl-1-benzyloxybenzene derivatives, useful as pesticides for plant protection and preservation of technical products, and as intermediates for active compounds
11/21/2002CA2447416A1 Substituted benzoylcyclohexenones and their use as herbicidal agents
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090314A1 Pyruvate derivatives
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002DE10216686A1 Additive for use in lubricants, has 2,5-dimercapto-1,3,4-thiadiazole derivative, and exhibits improved Timken loads
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/12/2002US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002US6479481 Administering an effective dose of a cns tumor-inhibiting methylol transfer agent such as: taurolidine, taurultam or a mixture thereof.
11/07/2002WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/06/2002EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002EP1254135A2 Aminoheterocyclylamides as pesticides and antiparasitic agents
11/05/2002US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002WO2002085291A2 Nociceptin analogs
10/31/2002WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/30/2002EP1253142A1 Compounds exhibiting thrombopoietin receptor agonism
10/30/2002EP0793660B1 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
10/24/2002WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002US20020156286 Solvent extraction
10/24/2002US20020156069 Benzo thiadiazine matrix metalloproteinase inhibitors
10/24/2002US20020156061 Administering to a mammal a matrix metalloproteinase inhibiting amount of derivatives of isophthalic acid, isophthalic acid ester or isothalamide compounds to treat cancer, rheumatic arthritis atherosclerosis and osteoporosis
10/22/2002US6469175 Solvent extraction
10/22/2002US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/17/2002WO2002081438A2 Process for producing thiosemicarbazides
10/17/2002WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002WO2002081426A1 Peptide deformylase inhibitors
10/17/2002WO2002050081A3 Antimicrobial agents
10/17/2002US20020151524 Aromatic fungicide compound containing N=C-G group wherein G= O, S, S=O, S(O)2 or N(NRR')
10/17/2002CA2446918A1 Process for producing thiosemicarbazides
10/16/2002EP1249233A1 Npyy5 antagonists
10/16/2002EP1248625A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors
10/16/2002EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002EP0941218B1 Antithrombotic organic nitrates
10/16/2002EP0934316B1 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/10/2002WO2002078596A2 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic diazo dye
10/10/2002WO2001072685A9 Polyamine analogues as cytotoxic agents
10/09/2002EP1247524A1 Composition comprising taurolidine and/or taurultam for the treatment of cancer
10/09/2002EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002EP1246617A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
10/09/2002CN1373754A Antibacterial agents
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/03/2002WO2002076961A1 7-nitro-2,1,3-benzoxadiazole derivatives and 7-nitro-2,1,3-benzthiadiazole derivatives and dyes, which contain these compounds and which are used for dying keratin fibers
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002CA2692295A1 Combined use of methylol-transfer agents and fas-ligands in the treatment of cancer
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1246006A2 Dye-forming coupler, silver halide photographic light-sensitive material and azomethine dye compound
10/02/2002CN1091766C Prenyl transferase inhibitors
10/01/2002US6458845 Macrophage scavenger receptor antagonists
09/2002
09/26/2002WO2002074736A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
09/26/2002WO2002074268A2 Dyeing compositions for the dyeing of keratin fibres, comprising heterocyclic hydrazone compounds
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002028810A3 Retinoids for the treatment of emphysema
09/26/2002DE10113699A1 New 4-nitro-2,1,3-benzoxadiazole or -benzthiadiazole derivatives, used in hair dye compositions, have a substituted methylene group at position 7
09/25/2002EP1243577A1 Novel phenylalanine derivatives
09/24/2002US6455566 Substituted 1-aryl-3-heteroaryl-thioureas (or isothioureas) as antiatherosclerotic agents
09/24/2002US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/12/2002WO2002069901A2 Cathepsin cysteine protease inhibitors
09/12/2002US20020128232 Heterocyclic angiogenesis inhibitors
09/12/2002US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders
09/11/2002EP1237874A2 Selective neurokinin antagonists
09/11/2002EP0912504B1 Oxazolidine ester
09/06/2002WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067851A2 Method for treating fibrotic diseases or other indications iiic
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002CA2433425A1 Method for treating fibrotic diseases or other indications iiic
09/05/2002US20020123491 Selective neurokinin antagonists
09/04/2002CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group
09/04/2002CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds
09/04/2002CN1090019C 组合物 The composition
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
08/2002
08/28/2002EP1233958A1 Inhibitors of histone deacetylase
08/28/2002EP1233953A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
08/28/2002EP1233952A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/22/2002WO2002064578A1 Benzo thiadiazine matrix metalloproteinase inhibitors
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064135A1 Heterocyclic inhibitors of glycine transporter 2
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 100